Editorial Note
Sowmya Uttam
Abstract
A quality called MYC has gotten probably the most sweltering objective for disease specialists around the globe. MYC is known to drive tumor development in almost all disease types - however effectively focusing on the quality has demonstrated to be a test. One that has been astounding specialists for over three decades. Presently, scientists at Purdue University have found a novel arrangement of MYC advertiser G-quadruplex stabilizers that have shown anticancer action in human malignant growth cell societies. The revelation is distributed in the July 8 version of the Journal of the American Chemical Society.